Driehaus Capital Management
$17.3B 13F equity value
441 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Driehaus Capital Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| TSM | TSMC | 984,500 | $470M | 2.7% |
| DFTX | Definium Therapeutics Inc | 6,845,276 | $322M | 1.9% |
| PRAX | Praxis Precision Medicines Inc | 959,048 | $321M | 1.9% |
| XENE | Xenon Pharmaceuticals Inc | 4,418,557 | $267M | 1.5% |
| SIMO | Silicon Motion Technology Corp | 786,074 | $262M | 1.5% |
| SYRE | Spyre Therapeutics Inc | 2,799,166 | $249M | 1.4% |
| CRNX | Crinetics Pharmaceuticals Inc | 6,463,551 | $242M | 1.4% |
| APGE | Apogee Therapeutics Inc | 1,740,101 | $231M | 1.3% |
| GH | Guardant Health Inc | 1,533,985 | $230M | 1.3% |
| PL | Planet Labs PBC | 6,721,154 | $223M | 1.3% |
Track Driehaus Capital Management's 13F portfolio: $17.3B in reported holdings, 441 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}